Leo Pharma chairman: "In the long term, we will probably have fewer employees"

The pharmaceutical company's ownership circle, including Nordic Capital, is accelerating the transformation of Leo Pharma, and according to Chairman of the Board Jesper Brandgaard this could mean fewer employees in the long term.

BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY DANIEL PEDERSEN

Published: 14.10.21 at 13:06

Leo Pharma's transformation is moving up a gear, and according to Chairman of the Board Jesper Brandgaard, this could have consequences for the company's staff, which today counts 5,800 people, reports Danish business daily Børsen.

"What the count will be, time will tell. We don't have a specific target we have to reach. In the long term, we will probably have fewer employees," Brandgaard tells Børsen.

Already a subscriber? Log in.

Read the whole article

Get 14 days free access.
No credit card required.

Start a free company trial today

Lundbeck chairman demands change: "We can't live with this"

Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.